Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Rabix-VC Rabies Vaccine in Healthy Adults
NCT04715867Phase 1Unknown
- Sponsor
- icddr,b
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of rabies vaccine in rabies (4 arms), sponsored by icddr,b. Primary endpoint: Analysis of immunogenicity by Seroconversion at 1 year. Status: unknown.
02
Drugs
rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT04715867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04715867.